Treatment of chronic actinic dermatitis with tacrolimus ointment

Journal of the American Academy of Dermatology

Volumn 47, Issue 6, 2002, Pages 881-884

  Uetsu, Naoko ^a   Okamoto, Hiroyuki ^a   Fujii, Keiko ^a   Doi, Risa ^a   Horio, Takeshi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; SUNSCREEN; TACROLIMUS;

ACTINIC DERMATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; DRUG EFFECT; DRUG TOLERABILITY; FACE; HUMAN; HUMAN TISSUE; MALE; NECK; OINTMENT; OPEN STUDY; PRIORITY JOURNAL; SIDE EFFECT; SKIN IRRITATION; SYMPTOM; TREATMENT OUTCOME;

EID: 0036895192     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124703     Document Type: Article

References (20)

1. Hawk J, Cheong W-K. Chronic actinic dermatitis. In: Lim HW, Soter NA, editors. Clinical Photomedicine. New York: Marcel Dekker; 1993. p. 193-205.
2. Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy. J Am Acad Dermatol 2001;44:S28-38.
3. Soter NA, Fleisher AB, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol 2001;44:S39-46.
4. Aoyama H, Tabata N, Tanaka M, Uesugi Y, Tagami H. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK-506 ointment [letter]. Br J Dermatol 1995;133:494-6.
5. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficiency of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001;44:S58-S64.
6. Nakagawa H. Comparative study of FK506 (tacrolimus) ointment vs. alclometasone dipropionate ointment in atopic dermatitis (face and neck lesions) [abstract]. J Invest Dermatol 1998;110:683.
7. Reitano S, Rissanen J, Remitz A, Granlund H, Erkko P, Elg P, et al. Tacrolimus ointment does not affect collagen synthesis: Results of a single-center randomized trial. J Invest Dermatol 1998;111:396-8.
8. Meingassner JG, Stutz A. Immunosuppressive macrolides of the type FK506: A novel class of topical agents for treatment of skin disease? J Invest Dermatol 1992;98:851-5.
9. Hisatomi A, Mitamura T, Kimura M, Oishi Y, Fujii T, Ohara K. Comparison of FK506 (tacrolimus) and glucocorticoid ointment on dermal atrophogenicity in rats. J Toxicol Pathol 1997;10:97-102.
10. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506: In vitro effects on cloned T-cell activation. J Immunol 1987;139:1797-803.
11. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today 1992;13:136-42.
12. MeingassnerJG, StutzA. Anti-inflammatory effects of macrophilin-interacting drugs in animal models of irritant and allergic contact dermatitis. Int Arch Allergy Immunol 1992;99:486-9.
13. Sengoku T, Morita K, Sato S, Sakuma S, Ogawa T, Hiroi J, et al. Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice. Folia Pharmacol Jpn 1998;112:221-32.
14. Duncan JI. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK506, and rapamycin. J Invest Dermatol 1994;102:84-8.
15. Horio T. Actinic reticuloid via persistent light reaction from photoallergic contact dermatitis. Arch Dermatol 1982;118:339-42.
16. Miyauchi H, Horio T, Asada Y, Hayami M. Chronic actinic dermatitis: A time course study of histopathological changes. Photodermatol Photoimmunol Photomed 1991;8:65-8.
17. Leigh IM, Hawk J. Treatment of chronic actinic dermatitis with azathioprine. Br J Dermatol 1984;110:691-5.
18. Murphy GM, Maurice P, Norris PG, Morris RW, Hawk J. Azathioprine in the treatment of chronic actinic dermatitis: A double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 1989;121:639-46.
19. Norris PG, Camp R, Hawk J. Actinic reticuloid: Response to cyclosporin. J Am Acad Dermatol 1989;21:307-9.
20. Duschet P, Schwarz T, Oppolzer G, Gschnait F. Persistent light reaction: Successful treatment with cyclosporin A. Acta Derm Venereol(Stockh) 1988;68:176-8.